Dr. Reddy's launches generic Xopenex

HYDERABAD, India — Dr. Reddy's Labs on Wednesday announced the launch of levalbuterol inhalation solution, USP in 0.31-mg, 0.63-mg and 1.25-mg unit-dose vials. The drug is the generic version of Xopenex (levalbuterol hydrochloride) inhalation solution from Sunovion Pharmaceuticals.

 

The branded and generic form of the drug had combined sales in the United States of approximately $269.7 million for the 12 months ending in June 2014 according, to IMS Health.